- States’ regulations and MCO guidelines may restrict, or at a minimum, discourage carriers and employers from considering treatment in another state where they may lose control of the injury claim.
- State fee schedules may be misaligned with applying a value based, bundled price for treatment in a state outside of where the injury occurred, and the claimant resides.
- Direction of care statutes may prevent employees from being channeled to a provider outside of their choosing, much less in another state.
- There isn’t always “goodwill” between an employee and their employer after an injury. The concept of sending the employee out of state for care may not be a comfortable proposition for either party.
- Since there is no financial participation on behalf of the employee, compliance with set appointments may be an issue.
- Workers’ compensation adjusters prefer to have specified workflows and may be hesitant to inject intra-state travel coordination tasks and “unknowns” to their heavy caseload.
- The indemnity costs, time off work, and disability assessment could be negatively impacted by any incidental injury /episode which may occur during the claimants’ travels to a center of excellence.
- Where would the funding for a caregiver’s travel with the claimant come from and how would it be accounted for in the claim? Who would be responsible if the caregiver suffers an injury during travel with the claimant?
- Who would be responsible for clinically managing the workers’ compensation care (primary treating physician) and coordinating / submitting the necessary state forms?
More stories
Investigating the Top Therapeutic Classes
First Script saw a decrease in opioid utilization across our retail and mail-order programs in 2018. In 2017, opioids made up 29.7% of total prescriptions, dropping to 26.9% in 2018, and representing a 2.8% decrease in utilization year over year.
Secrets to a Successful Stay At Work Program
A good stay-at-work program can offer many benefits to employees and employers, but establishing a successful plan can sometimes be a challenge. To help make this process easier, I'm joined by Genex experts Kevin Ufier and Linda Mastropaolo who will offer tips on how to develop a successful program.
Opioids in 2019: Insights into New Regulations and Studies of the Epidemic
Momentum in battling the opioid crisis continues. As more states enact opioid prescribing limits, the federal government proposes new legislation, while new studies look at the impact of opioid laws and medical marijuana on lessening opioid abuse.
How Naloxone Can Help Fight the Opioid Crisis
As the U.S. looks for ways to stem the opioid crisis, one major strategy that has emerged is the use of naloxone to counteract opioid overdoses. The FDA’s recent approval of the generic form of Narcan®, which is the first generic formulation for naloxone nasal spray, provides another avenue to reverse the impact of the opioid crisis.
Morphine Equivalent Dose (MED) Continues to Decline
In 2018 Coventry’s pharmacy benefit management solution, First Script®, saw a 7.8% decrease in average MED per prescription for its retail and mail-order channels. This was the largest decrease in the last 5 years across First Script’s retail and mail-order programs. In addition, there was a reduction in the percentage of opioid scripts with greater than or equal to 90 MED. To better understand why this is important let’s answer a few questions.
Humanizing the Collision Claims Experience in the Digital Age
Today’s customers have high expectations. From ordering coffee to online banking, they experience personalized, on-demand service from the businesses they interact with, and they expect the same from their insurers. How can insurance claims organizations adapt to a digital world and continue to exceed customer expectations? Start by reading these five tips from industry experts for humanizing the collision claims experience.